The time has come: a new scene for PKU treatment
Genet. mol. res. (Online)
;
5(1): 33-44, Mar. 31, 2006. tab, ilus
Article
in English
| LILACS
| ID: lil-449148
ABSTRACT
Phenylketonuria (PKU) is one of the few genetic diseases in which mental retardation can be prevented. Hence, diagnosis and treatment must be established early. PKU treatment consists of a phenylalanine-restricted diet supplemented with a phenylalanine-free mixture of amino acids. However, it is difficult to adhere to this diet. In the last decade, a better comprehension of the biochemistry, genetics and molecular basis of the disease, as well as the need for easier treatment, led to the development of several new therapeutic strategies for PKU. In the present study, we evaluated these new therapeutic options in terms of theoretical basis, methodologies, efficacy, and costs.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Phenylalanine Hydroxylase
/
Phenylketonurias
/
Food, Formulated
/
Diet, Protein-Restricted
Limits:
Humans
Language:
English
Journal:
Genet. mol. res. (Online)
Journal subject:
Molecular Biology
/
Genetics
Year:
2006
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de Minas Gerais/BR
Similar
MEDLINE
...
LILACS
LIS